First case of post-endoscopic retrograde cholangiopancreatography bacteraemia caused by Acinetobacter ursingii in a patient with choledocholithiasis and cholangitis.
We describe what we believe to be the first case of biliary sepsis caused by Acinetobacter ursingii. The patient was a healthy woman with no comorbidities who presented with choledocholithiasis and cholangitis. The performance of an endoscopic cholangiopancreatography was the trigger for A. ursingii bacteraemia. This report highlights the inadequacies of conventional phenotypic tests usually available in clinical microbiology laboratories for the identification of Acinetobacter species.
de la Tabla Ducasse
Victoria Ortiz
VO
Microbiology Service, Hospital Universitario San Juan de Alicante, Spain.
González
Coral Martín
CM
Microbiology Service, Hospital Universitario San Juan de Alicante, Spain.
Sáez-Nieto
Juan A
JA
Taxonomy Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Gutiérrez
Félix
F
Infectious Diseases Unit, Department of Medicine, Hospital General Universitario de Elche, Universidad Miguel Hernández, Elche, Spain.
D000150:Acinetobacter / Q000145:classification / Q000302:isolation & purification; D000151:Acinetobacter Infections / Q000188:drug therapy / Q000209:etiology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D002439:Cefotaxime / Q000627:therapeutic use; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D002761:Cholangitis / Q000150:complications*; D042883:Choledocholithiasis / Q000150:complications*; D005260:Female; D006801:Humans; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D002439:Cefotaxime